B. Riley Securities, a full-service investment bank, served as the exclusive financial advisor to ChronoScale in the sale of its subsidiary, Ekso Bionics, to Wandercraft. The transaction closed on Sept. 30, 2026, and brings together two companies in robotic mobility.
This acquisition combines Wandercraft’s expertise in advanced robotics and physical AI and its leadership in EMEA with Ekso Bionics’ strong U.S. presence, extensive clinical experience and commercial reach. Together, they form a medical exoskeleton company, offering a broader portfolio of medical exoskeletons spanning the continuum of care, from rehabilitation to everyday personal mobility.
B. Riley Securities’ deal team included Thomas McGlynn, Elise Melconian, Noah Rich and Adam Huberman.
